Medical Devices Italy

Italy Rapid Antigen Tests Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Italy Rapid Antigen Tests Market Industry Trends and Forecast to 2034: Segmented by (Disease, User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Italy · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $237.2 Mn Placeholder estimate
Estimate 2025 $242.9 Mn 2.5% of the global market
Projected 2034 $300.6 Mn 23.8% Adds $57.8 Mn over 9 forecast years
CAGR 2025–2034 2.4% Faster than 0% of 173 Medical Devices markets here
Key players 5
  • Italy is 2.54% of the global market.
  • In Europe, the largest is Germany at $297.9 Mn.
  • Fastest growing: Russia at 3% a year.
  • Italy ranks 4th of 6 by size in Europe.

Market size projection

Italy

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$57.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Rapid Antigen Tests Market market size by year, Italy
YearMarket sizeChange that yearSince 2025
2024 (estimate) $237.2 Mn — —
2025 (base) $242.9 Mn +$5.7 Mn —
2026 (forecast) $248.7 Mn +$5.8 Mn +2.4%
2027 (forecast) $254.6 Mn +$6.0 Mn +4.9%
2028 (forecast) $260.8 Mn +$6.1 Mn +7.4%
2029 (forecast) $267.0 Mn +$6.3 Mn +10%
2030 (forecast) $273.4 Mn +$6.4 Mn +12.6%
2031 (forecast) $280.0 Mn +$6.6 Mn +15.3%
2032 (forecast) $286.7 Mn +$6.7 Mn +18.1%
2033 (forecast) $293.6 Mn +$6.9 Mn +20.9%
2034 (forecast) $300.6 Mn +$7.0 Mn +23.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Italy Rapid Antigen Tests Market Analysis at a glance
Market size, 2025$242.9 Mn placeholder estimate
Forecast, 2034$300.6 Mn placeholder estimate
Growth (CAGR), 2025–20342.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDisease and user (see all)
Key playersAbbott Laboratories, Quidel Corporation, Roche Diagnostics, SD Biosensor, BD (Becton, Dickinson) (see all)
Regulator in ItalyMinistry of HealthSource: Italian Ministry of Health. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Italy Rapid Antigen Tests Market Analysis Executive Summary

Rapid antigen tests detect proteins from viruses or bacteria in minutes, used for flu, COVID-19, strep throat and more.

Key segments of the rapid Antigen Tests market include disease (Influenza, COVID-19 and Strep A) and user (Professional and Self-Test).

Bar chart: Italy Rapid Antigen Tests market size, 2024–2034, placeholder estimates. $237.2 Mn in 2024, $242.9 Mn in 2025 and $300.6 Mn in 2034, 2.4% CAGR.
Italy Rapid Antigen Tests market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Italy Rapid Antigen Tests Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the rapid Antigen Tests market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the rapid Antigen Tests market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the rapid Antigen Tests market.

Competitive Landscape for Rapid Antigen Tests Market in Italy

The rapid Antigen Tests market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Rapid Antigen Tests Market in Italy

Rapid Antigen Tests in Italy: rules and payment

Medical devices need CE marking under the EU Medical Device Regulation (MDR); the Ministry of Health oversees them in Italy.⁠[1] The National Health Service (SSN), run by the regions, gives universal cover, and AIFA decides which medicines it pays for.⁠[1]

[1] Italian Ministry of Health. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how rapid Antigen Tests products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Italy.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Rapid Antigen Tests right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Rapid Antigen Tests in context

Italy compared

  • Health spending per person: 3,398 US$ per person (2024). World: 1,317 US$ per person (2023). 4th highest of the 6 countries we cover in Europe.[1]
  • Doctors: 4.19 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 4th highest of the 6 countries we cover in Europe.[2]
  • People aged 65 and over: 25.1% of people (2025). World: 10.4% of people (2025). Highest of the 6 countries we cover in Europe.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Rapid Antigen Tests market in Italy?
Placeholder estimate: about $242.9 Mn in 2025, rising to about $300.6 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Rapid Antigen Tests market in Italy growing?
Placeholder estimate: about 2.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Rapid Antigen Tests market report cover?
The report splits the market by disease (Influenza, COVID-19, Strep A, RSV and more) and user (Professional, Self-Test).
Who are the key players in the Rapid Antigen Tests market?
Key players include Abbott Laboratories, Quidel Corporation, Roche Diagnostics, SD Biosensor and BD (Becton, Dickinson).
What is driving the Rapid Antigen Tests market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the rapid Antigen Tests market.
Who regulates Rapid Antigen Tests in Italy?
Medical devices need CE marking under the EU Medical Device Regulation (MDR); the Ministry of Health oversees them in Italy. Source: Italian Ministry of Health. Checked 14 Nov 2026.
How is healthcare paid for in Italy?
The National Health Service (SSN), run by the regions, gives universal cover, and AIFA decides which medicines it pays for. Source: Italian Ministry of Health. Checked 14 Nov 2026.
How much research is published on Rapid Antigen Tests?
PubMed lists 571 papers on Rapid Antigen Tests added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Italy

See all

Related on diagnostics and lab testing and infectious diseases

See the topic